LEXICON PHARMACEUTICALS, INC. Investment Income, Interest
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Investment Income, Interest of $5.00 thousand for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2014-11-06
- LEXICON PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2014-09-30 was $5.00K, a 87.18% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2014-06-30 was $4.00K, a 90.91% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2014-03-31 was $8.00K, a 84.91% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2013-12-31 was $21.00K, a 61.82% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for fiscal 2013 was $157.00K, a 26.29% decline from fiscal 2012.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for fiscal 2012 was $213.00K, a 16.47% decline from fiscal 2011.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for fiscal 2011 was $255.00K, a 50.87% decline from fiscal 2010.
- LEXICON PHARMACEUTICALS, INC. investment income, interest for fiscal 2010 was $519.00K, a 41.02% decline from fiscal 2009.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2014-09-30 | $5.00K 10-Q · filed 2014-11-06 | $9.00K derived: sum of 2 quarters · filed 2014-11-06 | $17.00K 10-Q · filed 2014-11-06 | $38.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | $4.00K 10-Q · filed 2014-08-07 | $12.00K 10-Q · filed 2014-08-07 | $33.00K derived: sum of 3 quarters · filed 2014-08-07 | $72.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-03-31 | $8.00K 10-Q · filed 2014-05-08 | $29.00K derived: sum of 2 quarters · filed 2014-05-08 | $68.00K derived: sum of 3 quarters · filed 2014-11-06 | $112.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $60.00K derived: sum of 2 quarters · filed 2014-11-06 | $104.00K derived: sum of 3 quarters · filed 2014-11-06 | $157.00K 10-K · filed 2014-03-07 |
| 2013-09-30 | $39.00K 10-Q · filed 2014-11-06 | $83.00K derived: sum of 2 quarters · filed 2014-11-06 | $136.00K 10-Q · filed 2014-11-06 | $191.00K derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | $44.00K 10-Q · filed 2014-08-07 | $97.00K 10-Q · filed 2014-08-07 | $152.00K derived: sum of 3 quarters · filed 2014-08-07 | $196.00K derived: sum of 4 quarters · filed 2014-08-07 |
| 2013-03-31 | $53.00K 10-Q · filed 2014-05-08 | $108.00K derived: sum of 2 quarters · filed 2014-05-08 | $152.00K derived: sum of 3 quarters · filed 2014-05-08 | $210.00K derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $99.00K derived: sum of 2 quarters · filed 2014-03-07 | $157.00K derived: sum of 3 quarters · filed 2014-03-07 | $213.00K 10-K · filed 2014-03-07 |
| 2012-09-30 | $44.00K 10-Q · filed 2013-11-12 | $102.00K derived: sum of 2 quarters · filed 2013-11-12 | $158.00K 10-Q · filed 2013-11-12 | $198.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $58.00K 10-Q · filed 2013-08-01 | $114.00K 10-Q · filed 2013-08-01 | $154.00K derived: sum of 3 quarters · filed 2014-03-07 | $214.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $56.00K 10-Q · filed 2013-05-10 | $96.00K derived: sum of 2 quarters · filed 2014-03-07 | $156.00K derived: sum of 3 quarters · filed 2014-03-07 | $224.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $100.00K derived: sum of 2 quarters · filed 2014-03-07 | $168.00K derived: sum of 3 quarters · filed 2014-03-07 | $255.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | $60.00K 10-Q · filed 2012-11-07 | $128.00K derived: sum of 2 quarters · filed 2012-11-07 | $215.00K 10-Q · filed 2012-11-07 | $266.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-06-30 | $68.00K 10-Q · filed 2012-08-02 | $155.00K 10-Q · filed 2012-08-02 | $206.00K derived: sum of 3 quarters · filed 2013-03-11 | $257.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2011-03-31 | $87.00K 10-Q · filed 2012-05-03 | $138.00K derived: sum of 2 quarters · filed 2013-03-11 | $189.00K derived: sum of 3 quarters · filed 2013-03-11 | $389.00K derived: sum of 4 quarters · filed 2013-03-11 |
| 2010-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $102.00K derived: sum of 2 quarters · filed 2013-03-11 | $302.00K derived: sum of 3 quarters · filed 2013-03-11 | $519.00K 10-K · filed 2013-03-11 |
| 2010-09-30 | $51.00K 10-Q · filed 2011-11-01 | $251.00K derived: sum of 2 quarters · filed 2011-11-01 | $468.00K 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $200.00K 10-Q · filed 2011-08-09 | $417.00K 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $880.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |